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Neutral O-linked oligosaccharides released from the salivary mucin MUC5B were separated
and detected by negative ion LC-MS and LC-MS2. The resolution of the chromatography and
the information obtained from collision induced dissociation of detected [M  H] ions were
usually sufficient to identify the sequence of individual oligosaccharides, illustrated by the fact
that 50 different oligosaccharides ranging from disaccharides to nonasaccharides could be
assigned from the sample. Fragmentation was shown to yield mostly reducing end sequence
fragments (Zi and Yi), enabling primary sequence assignment. Specific fragmentation path-
ways or patterns were also detected giving specific linkage information. The reducing end core
(Gal/GlcNAc1-3GalNAcol or Gal/GlcNAc1-3(GlcNAc1-6)GalNAcol) could be deduced
from the pronounced glycosidic C-3 cleavage and Ai type cleavages of the reducing end
GalNAcol, together with the non reducing end fragment from the loss of a single substituted
GalNAcol. Substitution patterns on GlcNAc residues were also found, indicative for C-4
substitution (0,2Ai  H2O cleavage) and disubstitution of C-3 and C-4 (Zi/Zi cleavages). This
kind of fragmentation can be used for assigning the mode of chain elongation (Gal1-3/
4GlcNAc1-) and identification of Lewis type antigens like Lewis a/x and Lewis b/y on
O-linked oligosaccharides. In essence, negative ion LC-MS2 was able to generate extensive data
for understanding the overall glycosylation pattern of a sample, especially when only a limited
amount of material is available. (J Am Soc Mass Spectrom 2004, 15, 659–672) © 2004
American Society for Mass SpectrometryIdentification and understanding of biological pro-cesses involving glycoconjugates is a scientific areaof increasing interest. This increase in interest has
worked hand in hand with the development of more
sensitive and specific analytical techniques in this field.
Mass spectrometry has been the detection and charac-
terization tool most frequently used in recent years for
analysis of glycoproteins, glycopeptides, glycolipids, or
free oligosaccharides (some reviews in [1–5]). In princi-
ple, mass spectrometry suffers from the fact that the
monomeric components (the monosaccharides) of oli-
gosaccharide chains consist of isomeric building blocks,
and that linkage configuration and position are difficult
to obtain with the technique. Even so, researchers have
applied mass spectrometric techniques to answer bio-
logical questions (some examples in [6–9]).
Characterization of released or free oligosaccharides
by mass spectrometry using electrospray ionization in
negative mode has recently been shown to give both
sequence and linkage information [10, 11]. Negative ion
mode has been shown to be applicable to both nega-
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saccharides [12–14], and offers high sensitivity of detec-
tion without requiring derivatization or adduct
formation to aid ionization. Electrospray is also easily
coupled to with high resolution liquid chromatography,
an important factor in resolving the degeneracy of
structural isomers found in oligosaccharide mixtures.
Mucin-type O-linked oligosaccharides are found
linked to serine and threonine via a GalNAca1-linkage.
These amino acids are often found as clustered domains
in the protein backbone, which leads to a high potential
for interaction through the subsequently closely spaced
oligosaccharides. For example, the ligands for E-, L-,
and P-selectin have all been shown to interact via their
clustered domains of sialylated and/or sulfated O-
linked oligosaccharides (reviewed in [15, 16]). A rich
source of O-linked oligosaccharides is the mucin pro-
teins found associated with cell membranes or secreted
from cells localized to mucosal surfaces [17]. Here,
mucins interact in the initial phase of microbial invasion
by exposing a wide variety of oligosaccharide epitopes
targeted towards microbial adhesins [18–20].
Isolation and full characterization of mucin oligosac-
charides usually requires several steps of isolation of
both mucin components and individual oligosaccha-
rides, followed by analytical techniques like 1H-HMR,r Inc. Received September 4, 2003
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simplify and cut this process short, we decided to find
out how much information could be obtained by the
more sensitive technique of negative ion MS2 in an ion
trap on-line with liquid chromatography using graphi-
tized carbon as stationary phase. O-linked oligosaccha-
rides are traditionally released from the protein core by
reductive -elimination. This procedure converts the
reducing end GalNAc into its alditol. Further derivati-
zation of the reducing end is thus made impossible, and
techniques, which have been developed for analysis of
reducing sugars by addition of a charged group in
order to promote ionization in mass spectrometry,
cannot be used. However, negative ion mode electros-
pray mass spectrometry of oligosaccharide alditols cir-
cumvents the need for derivatization. Since information
about fragmentation of oligosaccharide alditols using
negative ion collision induced dissociation is scarce,
there is a need to establish its usefulness for structural
characterization. Due to the absence of good commer-
cial standards of O-linked oligosaccharides, we decided
to isolate mucin oligosaccharides from easily available
mucin sources that express a wide variety of oligosac-
charide epitopes. This allowed us to draw general
conclusions about how oligosaccharide alditols frag-
ment. In this report we describe the negative ion mode
ES-MS2 fragmentation of neutral oligosaccharides
mainly isolated from the well characterized human
salivary MUC5B oligosaccharides [21].
Experimental
Isolation of Salivary MUC5B Mucins
Saliva (5–10 ml) from blood group H, blood group A/B,
and blood group A individuals was collected, reduced
and alkylated as described previously [14], and high
molecular mass proteins were collected after concen-
trating the samples to 500–1000 L in an Ultrafree-4
centrifugal filter (50 kDa cut off) (Millipore, Bedford,
MA). The high molecular mass fraction from each
individual was then loaded onto a preparative SDS-
polyacrylamide/agarose composite gel [14] without
sample wells. The gels were run, electroblotted and
stained with Alcian blue, and oligosaccharides were
released from the broad MUC5B containing band by
reductive -elimination as described [14].
Preparation of Oligosaccharides for LC-MS2
Oligosaccharides from porcine gastric mucins (1.0 mg)
(Sigma-Aldrich, St Louis, MO), rat intestinal Muc2 (1.0
mg) [22], and human salivary MUC5B were released in
1.0 mL of 0.5 M NaBH4 or NaBD4, both in 50 mM
NaOH. Samples were desalted with 1.0 mL of AG50W
2 cation exchange beads (Bio-Rad, Hercules, CA)
packed in a 1.0 mL Strata C18-E cartridge (Phenomenex,
Torrance, CA), and the oligosaccharides were eluted
with 10 mL of water and lyophilized. Borate complexeswere removed with repeated (5 times) addition of 1%
acetic acid in methanol (100 L each time), followed by
vacuum centrifugation. Remaining oligosaccharides
were dissolved in 1.0 mL of water. Neutral human
salivary and rat intestinal oligosaccharides (50 L of
each) were separated from the acidic oligosaccharides
by passage through 10 L of DEAE-Sephadex (Ac
form) (Amersham Biosciences, Uppsala, Sweden)
packed on top of a C18 Zip-tip (Millipore). Samples
were eluted with 200 L of water, dried and redissolved
in 50 L of water and subjected to LC-MS2, or to direct
infusion MSn.
MSn and LC-MS2 of Oligosaccharides
Direct infusion (50–250 L of 40% acetonitrile/10 mM
ammonium bicarbonate with a flow of 10–50 L/min)
was carried out of oligosaccharides released from an
equivalent of 0.1 mg mucin/mL. Mass spectra were
recorded in negative ion mode with a LCQ Deca XP
ESI-ion trap (ThermoFinnigan, San Jose, CA). Collisions
for MS2 and MS3 were carried out with an isolation
window of 3.0 u, a normalized collision energy of 40%,
and an activation time of 30 ms. Oligosaccharides (10
L of sample) were also analyzed by LC-MS2 as de-
scribed [14] using a graphitized carbon column (150 
0.32 mm) (Thermo Hypersil-Keystone, Runcorn, UK),
containing 5 m Hypercarb particles. Oligosaccharides
were eluted using a linear gradient from 0–25% aceto-
nitrile (25 min) in 10 mM ammonium bicarbonate with
a flow rate of 6–10 L/min and detected in the mass
spectrometer by full scan (mass range m/z 320-2000)
followed by 1–4 dependent MS2 scans of the 1–4 most
intense ions.
Results and Discussion
LC-MS of Neutral Oligosaccharide Aalditols by
HPLC Using Graphitized Carbon
The base source of neutral oligosaccharides was
MUC5B isolated from saliva of a blood group O, Leab
secretor by gel electrophoresis on composite agarose/
polyacrylamide gradient gels, but other sources were
also used to obtain a range of oligosaccharide structures
(Table 1). Neutral oligosaccharides from MUC5B anal-
ysed by LC-MS (Figure 1) were detected mostly as [M
H] ions and were eluted between 5–25 min in the
chromatogram. The chromatographic resolution of the
MUC5B associated oligosaccharides is shown in Figure
1a and the compositions of the major oligosaccharides
detected are shown in Figure 1b. The selectivity of the
carbon chromatography column allowed individual oli-
gosaccharide components to be isolated in the ion trap
for further collision and structural interpretation. This
enabled us to establish fragmentation pathways of
neutral oligosaccharide alditols in negative ion mode
MS and to identify diagnostic fragmentation patterns of
particular oligosaccharide epitopes, such as mucin oli-
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[M  H] ion
(observed)
RT
(min) Deduced sequence Core
Chain
type
Lewis
type
Blood
group
Salivary MUC5B from blood group H individual
384 6.4 Hex -3HexNAcol 1
425 7.2 HexNAc-3HexNAcol 3
530 20.3 Fuc-Hex-3HexNAcol 1 H
587 10.6 Hex-3(HexNAc-6)HexNAcola 2
587 12.5 Hex-4HexNAc-3HexNAcol 1
587 12.8 Hex-3HexNAc-3HexNAcol 3
587 12.8 HexNAc-Hex-3HexNAcol 1
628 11.9 HexNAc-3(HexNAc-6)HexNAcol 4
733 9.1 Hex-3/4(Fuc-3/4)HexNAc-3HexNAcol 3 NAb a/x
733 14.3 Fuc-Hex-3HexNAc-3HexNAcol 3 1 H
733 16.9 Fuc-Hex-4HexNAc-3HexNAcol 3 2 H
733 20.6 Fuc-Hex-3(HexNAc-6)HexNAcol 2 H
749 13.7 Hex-3(Hex-4HexNAc-6)HexNAcol 2 2
749 14.2 Hex-4HexNAc-Hex-3HexNAcol 1 2
790 14.3 HexNAc-3(Hex-4HexNAc-6)HexNAcol 4 2
879 13.4 Fuc-Hex-3/4(Fuc-3/4)HexNAc-3HexNAcol 3 NA b/y H
879 15.3 Fuc-Hex-3/4(Fuc-3/4)HexNAc-3HexNAcol 3 NA b/y H
895 11.9 Hex-3(Hex-3/4(Fuc-3/4)HexNAc-6)HexNAcol 2 NA a/x
895 14.9 Hex-3/4(Fuc-3/4)HexNAc-Hex-3HexNAcol 1 NA a/x
895 17.0 Hex-3(Fuc-Hex-4HexNAc-6)HexNAcol 2 2 H
895 20.8 Fuc-Hex-3(Hex-4HexNAc-6)HexNAcol 2 2 H
936 15.3 Fuc-Hex-3HexNAc-3(HexNAc-6)HexNAcol 2 1 H
936 17.5 HexNAc-3(Fuc-Hex-4HexNAc-6)HexNAcol 4 2 H
952 17.2 Hex-3HexNAc-3(Hex-3HexNAc-6)HexNAcol 4 1,1
1041 13.1 Hex-3/4(Fuc-3/4)HexNAc-(Fuc-)Hex-3HexNAcol 1 NA a/x
1041 14.1 Fuc-Hex-HexNAc-(Fuc-)Hex-3HexNAcol 1 NA H
1041 15.5 Fuc-Hex-3/4(Fuc-3/4)HexNAc-Hex-3HexNAcol 1 NA b/y H
1041 20.7 Fuc-Hex-3(Fuc-Hex-3HexNAc-6)HexNAcol 2 1 H,H
1041 21.9 Fuc-Hex-3(Fuc-Hex-4HexNAc-6)HexNAcol 2 2 H,H
1082 17.3 HexNAc-3(Fuc-Hex-3/4(Fuc-3/4)HexNAc-6)HexNAcol 4 NA b/y H
1098 14.6 Hex-3/4(Fuc-3/4)HexNAc-3(Hex-HexNAc-6)HexNAcol 4 NA,NA a/x
1098 16.2 Fuc-Hex-3HexNAc-3(Hex-3HexNAc-6)HexNAcol 4 1,1 H
1098 18.1 Hex-4HexNAc-3(Fuc-Hex-4HexNAc-6)HexNAcol 4 2,2 H
1098 19.1 Fuc-Hex-4HexNAc-3(Hex-HexNAc-6)HexNAcol 4 2,NA H
1114 16.0 Hex-HexNAc-(Hex-HexNAc-)Hex-3HexNAcol 1 NA,NA
1187 16.3 Fuc-Hex-3/4(Fuc-3/4)HexNAc-3(Fuc-)Hex-3HexNAcol 1 NA b/y H
1187 21.9 Fuc-Hex-3(Fuc-Hex-3/4(Fuc-3/4)HexNAc-6)HexNAcol 2 NA b/y H,H
1244 17.8 Hex-HexNAc-3(Fuc-Hex-(Fuc-3/4)HexNAc-6)HexNAcol 4 NA,NA b/y H
1244 18.8 Fuc-Hex-3HexNAc-6(Fuc-Hex-4HexNAc-6)HexNAcol 4 1,2 H,H
1244 21.7 Fuc-Hex-4HexNAc-3(Fuc-Hex-4HexNAc-6)HexNAcol 4 2,2 H,H
1260 14.9 Hex-3/4(Fuc-3/4)HexNAc-(Hex-HexNAc-)Hex-3HexNAcol 1 NA,NA a/x
1260 16.3 Hex-3/4(Fuc-3/4)HexNAc-(Hex-HexNAc-)Hex-3HexNAcol 1 NA,NA a/x
1260 18.0 Fuc-Hex-4HexNAc-(Hex-HexNAc-)Hex-3HexNAcol 1 2,NA H
1390 18.6 Fuc-Hex-3HexNAc-3(Fuc-Hex3/4(Fuc-3/4)HexNAc-6)HexNAcol 4 1,NA b/y H,H
1390 19.1 Fuc-Hex-3/4(Fuc-3/4)HexNAc-3(Fuc-Hex-4HexNAc-6)HexNAcol 4 NA,2 b/y H,H
1406 15.5 Fuc-Hex-3/4(Fuc-3/4)HexNAc-Hex-3(Hex-HexNAc-6)HexNAcol 2 NA,NA b/y H
1479 17.1 Hex-HexNAc-(Hex-HexNAc-)Hex-3(Hex-HexNAc-6)HexNAcol 2 NA, NA, NA
1552 18.8 Hex-3/4(Fuc-3/4)HexNAc-(Fuc-Hex-3/4(Fuc-3/4)HexNAc-)Hex-3HexNAcol 1 NA,NA a/x, b/y H
1625 18.3 Hex-3/4(Fuc-3/4)HexNAc-(Hex-HexNAc-)Hex-3(Hex-HexNAc-6)HexNAcol 2 NA,NA,NA a/x
1625 18.3 Hex-3/4(Fuc-3/4)HexNAc-Hex-HexNAc-Hex-3(Hex-HexNAc-6)HexNAcol 2 NA a/x
Salivary MUC5B from blood group A individual
1390 Fuc-Hex-3(Fuc-(HexNAc-)Hex-3/4(Fuc-3/4)HexNAc-6)HexNAcol 2 NA b/y H,A
Salivary MUC5B from blood group A/B individual
1349 Fuc-Hex-3(Fuc-(Hex-)Hex-3/4(Fuc-3/4)HexNAc-6)HexNAcol 2 NA b/y H,B
Rat intestinal Muc2
1041 Fuc-Hex-3(Fuc-Hex-4HexNAc-6)HexNAcol 2 2 H,H
Porcine gastic mucins
530 Fuc-Hex-3HexNAcol 1 H
733 Fuc-(HexNAc-)Hex-3HexNAcol 1 A
aBold letters indicate the C-6 branch of the HexNAcol.
bNA means not assigned.
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tion, and blood group related epitopes like ABO and
Lewis like epitopes. The molecular bases of these
epitopes are described in Table 2.
Fragmentation of [M  H] Ions of Neutral
Mucin Oligosaccharide Alditols
The ability to obtain specific sequence information by
fragmentation of oligosaccharides requires not only
detection of sequence specific fragment ions, but also
that information about linkage position and configura-
tion is obtain. While fragmentation with mass spectro-
metry may not be the optimal method to obtain this
information, its sensitivity and capacity for automation
makes the technique very attractive as a first approach
for structural characterization. In Figure 2, MS2 frag-
ment ion spectra of five different isomers with the
Figure 1. LC-MS of neutral MUC5B mucin
chromatogram where the major composition i
spectrum showing the combined spectra acquir
[Hex,HexNAc,dHex], including the reducing enoligosaccharide alditols. (a) shows the base peak
n each peak is labeled and (b) shows a composite
ed between 5–25 min. Compositions are assigned as
d GalNAcol as HexNAc.Table 2. Oligosaccharide epitopes on mucin oligosaccharides
Epitope Structure
Core type
Core 1 Gal1-3GalNAc
Core 2 Gal1-3(GlcNAc1-6)GalNAc
Core 3 GlcNAc1-3GalNAc
Core 4 GlcNAc1-3(GlcNAc1-6)GalNAc
N-Acetyllactosamine elongation type
Type 1 Gal1-3GlcNAc1-
Type 2 Gal1-4GlcNAc1-
Terminal structures
Lewis a Gal1-3(Fuc1-4)GlcNAc1-
Lewis b Fuc1-2Gal1-3(Fuc1-4)GlcNAc1-
Lewis x Gal1-4(Fuc1-3)GlcNAc1-
Lewis y Fuc1-2Gal1-4(Fuc1-3)GlcNAc1-
Blood group H Fuc1-2Gal1-
Blood group A Fuc1-2(GalNAc1-3)Gal1-
Blood group B Fuc1-2(Gal1-3)Gal1-
6.2.
663J Am Soc Mass Spectrom 2004, 15, 659–672 NEUTRAL O-LINKED OLIGOSACCHARIDE ALDITOLScomposition dHex1Hex1HexNAc1HexNAcol1 ([M 
H] ions of m/z 733) illustrate that different specific
complex fragmentation patterns can be obtained for
Figure 2. LC-MS2 spectra and assigned structur
m/z 733 corresponding to [dHex1Hex1HexNAc1
tion time 22.6, (b) retention time 18.3, (d) retenti
from porcine gastric mucins (c) retention time 1tetrasaccharides with the same composition. Assigning
fragment ions from the tetrasaccharide collision spectra
showed that differences are related to the structural
isomeric oligosaccharides with [MH] ion of
Acol1] isolated from human MUC5B (a) reten-
e 15.8, and (e) retention time 10.9 and isolatedes of
HexN
on tim
664 KARLSSON ET AL. J Am Soc Mass Spectrom 2004, 15, 659–672features of the oligosaccharides. Fragment ions were
shown to correspond both to cleavages in the glycosidic
bond (Bi and Ci for non-reducing end fragments and Yi
and Zi for the reducing end), and some cross ring
cleavages (Ai and Xi)(nomenclature according to Do-
mon and Costello [23]). Both single event cleavages and
internal fragments were seen. Also, some odd fragment
ions were detected like [M  H]  C3H8O4, B2 
C2H4O2, and Z2  CH4O2 (Figure 2). These ions to-
gether with other specific fragment ions were further
analyzed as described later on in the text. The knowl-
edge obtained from fragmentation of small oligosaccha-
rides was used for interpreting spectra of larger and
more complex structures. In Figure 3 it is shown that
the branching pattern can be determined for four dif-
ferent spectra of Core 4 hexasaccharides with the same
composition dHex1Hex2HexNAc2HexNAcol1 ([M 
H] ions of m/z 1098) and in Figure 4 the spectra
illustrate how the ABO-phenotype of human individu-
als are reflected on MUC5B Core 2 structures of deca- or
nona-saccharides. In general, accompanying the intense
glycosidic cleavages in all spectra were less intense
fragments corresponding to loss of 42 u (C2H2O) or 60 u
(C2H4O2) (for example m/z 876.1, m/z 673.1, and m/z
527.1 Figure 3) that could arise either from cross-ring
cleavages and/or full or partial loss of side groups.
Fragmentation of Core 1 (Gal1-3GalNAcol) and
Core 3 (GlcNAc1-3GalNAcol) Structures
One of the most pronounced features found for mucin
type O-linked oligosaccharide alditols with a singly C-3
substituted reducing terminus GalNAcol (Core 1 and
Core 2) was the ion with a loss of 223 u (from loss of the
reducing end HexNAcol) from the pseudomolecular
ion (resulting in m/z 510 in Figure 2b–e and m/z 307 in
Figure 5b). This B type ion could usually be seen above
10% intensity relative to the base peak in MS2-spectra of
low molecular mass oligosaccharide Core 1 and Core 3
structures (Figure 2b–e and Figure 5b), but its intensity
decreased as the size of the oligosaccharide increased.
Core 1 and Core 3 containing structures also consis-
tently showed an additional characteristic ion, the loss
of 108 u (C3H8O4) from the [M  H]
 ion (resulting in
m/z 625 in Figure 2b–e and m/z 422 in Figure 5b). This
was believed to be due to fragmentation within the
GalNAcol moiety, but further MS3 fragmentation of this
ion did not yield more information about this fragment,
since no additional cleavages within GalNAcol could be
found in the MS3-spectrum (data not shown). A second
approach to determine the origin of this 108 u loss was
devised where oligosaccharides were reduced by so-
dium borodeuteride instead of borohydride. This in-
creases the mass of the reducing end monosaccharide
unit by 1 u and accordingly increases the mass of all
fragment ions containing the deuterated C-1 of the
GalNAcol. To obtain high quality MS2 spectra from a
Core 1 type structure, oligosaccharides from porcinegastric mucins were released in the presence of sodium
borohydride or sodium borodeuteride and introduced
to the MS source by direct infusion. The pseudomolecu-
lar ions (m/z 530 and 531, respectively) corresponding to
the non-deuterated and deuterated structure dHex1-
2Hex1-3HexNAcol were chosen for collision (Figure 5).
It was shown that the [M  H]  C3H8O4 ( 108 u)
fragment ion included the C-1 of the GalNAcol, since
the deuterated sample showed a fragment ion of m/z
423.0 while the non-deuterated sample gave m/z 422.1.
It was thus possible to narrow down the possibilities for
the identity of this fragment ion, concluding that it
could be derived from either the loss of C-4, C-5, and
C-6 of the GalNAcol or alternatively a fragment losing
C-6 together with the acetyl group on the amide on C-2
(Figure 5). The [MH]  108 fragment ion was never
found in structures with substitution on both C-3 and
C-6 of the GalNAcol (i.e., Core 2 and Core 4 structures,
see for example Figure 2a), nor could it be observed
when only the C-6 was elongated (unpublished data).
One observation that cannot be easily explained is
that low molecular weight Core 1 and Core 3 structures
(up to trisaccharides) usually gave intense Y1- or Z1-
fragment ions (only the reducing terminus GalNAcol),
while larger structures gave less intense GalNAcol
fragments (10%). This coincided with a shift from that
the Z1 fragment ion being the more intense towards that
the Y1 fragment ion becoming the more intense of the
two as seen by comparing Figure 5b (Z1 ion of m/z 203.9)
with Figure 2c–e (Y1 ion of m/z 222.0).
Fragmentation of Core 2 (Gal1-3(GlcNAc1-
6)GalNAcol) and Core 4 (GlcNAc1-
3)(GlcNAc1-6)GalNAcol) Structures
By far the most common extensions of the reducing
terminal GalNAcol are structures with both a C-3 and a
C-6-branch (Core 2 and Core 4 structures). This is also
the case for the MUC5B oligosaccharides described in
Table 1. Characteristic MS2 fragmentation is exempli-
fied for Core 2 in Figure 2a, Figure 4, and Figure 6a and
for Core 4 in Figure 3. In order to determine which
substituents are attached to which branch of GalNAcol,
it is important to understand the fragmentation of the
linear GalNAcol. It has previously been reported that a
cleavage of the GalNAcol between C-4 and C-5 (desig-
nated as an 4Ai cleavage in this report) reveals the
composition of the substituent on C-6 [14]. This cleav-
age was also found to occur in the structures described
in this paper. In order to confirm the identity of this
4A4 fragment ion on a Core 2 structure, an MS
3
experiment was carried out using the intense [M  H]
ion of m/z 1041 from Muc2 oligosaccharides released
from rat small intestine [22] (Figure 6). This parent mass
corresponds to a blood group H structure with Fuc1-
2Gal1- on the C-3 branch of GalNAcol and Fuc1-
2Gal1-4GlcNAc1- on the C-6 branch. The collision
spectra (Figure 6b) of the 4A fragment ion (m/z 570.1)4
665J Am Soc Mass Spectrom 2004, 15, 659–672 NEUTRAL O-LINKED OLIGOSACCHARIDE ALDITOLSFigure 3. LC-MS2 spectra and assigned structures of isomeric Core 4 O-linked oligosaccharides with
[M  H] ion of m/z 1098 corresponding to dHex1Hex2HexNAc2HexNAcol1 isolated from human
MUC5B (a) retention time 19.1, (b) retention time 18.1, (c) retention time 16.2, and (d) retention time 14.9.
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with the addition of C-5 and C-6 of the GalNAcol, thus
confirming the fragmentation between C-4 and C-5 of a
GalNAcol substituted on C-6. The fragment is described
here in its enol form with a double bound between C-5
and C-6, but there is also the possibility that the
fragment exists in its aldehyde form, or that the ob-
served fragment ion is a mixture of both.
Figure 4. LC-MS2 of blood group determinant
Core 2 O-linked oligosaccharides. (a) Oligosacc
NAc1-3(Fuc1-2)Gal 1-) on the C-6 branch of G
structure with a blood group B (Gal1-3(Fuc1-2
blood group H structure without A or B extensIn all the MS2-spectra analyzed it was found that
cleavage of the glycosidic linkage between C-3 of the
GalNAcol and its extension gave intense reducing end
fragmentation. MS2 of Core 2 oligosaccharides always
gave Zi fragment ions from the GalNAcol C-3 branch
cleavages among the most intense in the spectrum (e.g.,
Figure 6a). The fragment ions from cleavage of the
equivalent glycosidic bond of Core 4 oligosaccharides
ded Lewis b/y containing oligosaccharides on
e containing a blood group A structure (Gal-
col with a [MH] ion of m/z 1390. (b) Similar
1-) with a [M  H] ion of m/z 1349. (c) Similar
ith a [M  H] ion of m/z 1187.exten
harid
alNA
)Gal
ion w
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or Zi fragmentation) depended on the type of additional
elongation.
Elongation of the Oligosaccharide by Type 1
(Gal1-3GlcNAc1-) and Type 2 (Gal1-
4GlcNAc1-) Chains
While most of the intense ions for sequence information
by MS2 are obtained by intense reducing end glycosidic
cleavages, the mucin oligosaccharide Type 2 chain has
been shown to give a specific 0,2Ai cleavage of the 4
substituted GlcNAc [14]. In small Type 2 elongated
Core 3 structure this fragment (m/z 408.8) dominates the
spectrum (Figure 2b), but in more complex structures it
is of lower intensity (5–10 %) (Figure 3a–b and Figure
6a). By further fragmentation with MS3 of this ion
(Figure 6c) it was shown that water from the 0,2A3
cleavage is eliminated from the remnant of the GlcNAc.
This enabled us to propose a structure of the 0,2A3 
H20 fragment ion where the GlcNAc moiety is con-
verted into an enone type structure as described in the
Figure 6c. The MS3 fragments that are derived from the
0,2A  H 0 fragment ion of m/z 409 are all directed
Figure 5. (a) Assigned fragmentation and MS
sodium borohydride or with (c) sodium borode3 2towards the reducing end, indicating that the charge of
the fragment is not held by the formed enone structure,
but rather kept at other sites of the molecule.
While there was no single ion that was diagnostic for
Type 1 structures, there were other features in the MS2
spectra that could be used for deducing their presence
of Type 1 elongation. Using the absence of 0,2Ai  H20
fragment ions as indicative of Type 1 structures it was
discovered that the C-3 glycosidic cleavages of the
GalNAcol of Core 2 and Core 4 structures gave almost
equal intensity of the Yi- and Zi-cleavages if a Type 1
sequence was directly attached to the C-3 (exemplified
in Figure 3c), while attachment of Type 2 structures
gave predominantly Zi type cleavage (Figure 3a).
Fucosylated Terminal Structures, Lewis a/x
(Gal1-3/4 (Fuc1-4/3)GlcNAc1-) and Lewis b/y
(Fuc1-2Gal1-3/4 (Fuc1-4/3)GlcNAc1-)
The presence of a C-3 and C-4 doubly substituted
GlcNAc gave rise to some unusual MS2-fragmentation
(Figure 2e). It was found that the two substituents on
GlcNAc eliminated in what looked like a simultaneous
event. We speculated on the formation of a conjugated
ctra of dHex-2Hex-3HexNAcol reduced by (b)
e. Samples introduced by direct infusion.2-spe
uterid
668 KARLSSON ET AL. J Am Soc Mass Spectrom 2004, 15, 659–672Figure 6. Assigned fragmentation and collision-spectra of dHex-2Hex-3(dHex-2Hex-4HexNAc-
6)HexNAcol from rat small intestine Muc2. (a) MS2-spectrum of the [M  H] ion of m/z 1041, (b)
MS3-spectrum of the fragment ion of m/z 570.1 (4A4 fragment for identification of the GalNAcol C-6
branch), and (c) MS3-spectrum of the fragment ion of m/z 408.9 [0,2A3  H20 fragment for
identification of the Type 2 chain (Gal1-4GlcNAc1-)]. Sample introduced by direct infusion.
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NAc residue. The fragmentation observed suggested
that the formation of a diene product could proceed by
elimination of the C-3 and C-4 substituents of the
GlcNAc and the proton on C-2 and either the C-5
proton (the Zi/Zi fragment ion in Figure 2e, Figure 3d,
and Figure 7a), or the carbon™carbon bond between C-5
and C-6 (the Zi/Zi  CH2O fragment in the same
figures). This latter fragment was detected 30 u lower
than the Zi/Zi ion. The hypothesis of a diene formation
was tested using the reduced Lewis a/x containing milk
oligosaccharide standards LNFP II (Gal1-3(Fuc1-
4)GlcNAc1-3Gal1-4Glc-ol) (MS2- spectra not shown)
and LNFP III (Gal1-4(Fuc1-3)GlcNAc1-3Gal1-
4Glc-ol) (Figure 7). Collision induced dissociation of
these two structures gave almost identical fragmenta-
tion in negative mode, where only minor differences in
intensity of detected fragment ions could be seen. This
indicates that it will be difficult to differentiate between
Lewis a and Lewis x by negative ion fragmentation.
Both LNFP II and LNFP III gave intense fragment
ions due to the diene formation of the 3,4-substituted
Figure 7. Assigned fragmentation and collisio
NAc1-3Gal1-4Glc-ol). (a) MS2-spectrum of the
fragment ion of m/z 480.1(Z3/Z3  CH2O) frag
GlcNAc. Sample introduced by direct infusion.GlcNAc. Further fragmentation of the Zi/Zi  CH2O
ion in MS3, gave fragments both from the reducing end
and the non-reducing end that confirmed for the pres-
ence of a GlcNAc-diene at the non-reducing end (Figure
7b showing LNFP III). This included the B2 (m/z 135.9)
and C2 (m/z 154.0) ions, which are fragments consisting
of only the GlcNAc diene and the Y2 (m/z 343.0) and Z2
(m/z 324.7) showing the single loss of a GlcNAc diene
from the parent ion. Both reducing and non-reducing
fragments were observed in the MS3 spectrum of LNFP
III. This indicates that the localization of the charge
within the parent ion does not contribute to the forma-
tion of the diene. Hence, charge remote fragmentation
appears to be one pathway for the formation of this
fragment.
The extension of the Lewis a and Lewis x epitopes
into Lewis b and Lewis y epitopes with a Fuc1-2
linked to the non-reducing end galactose was shown
not to inhibit the formation of the diene (Figure 4c), but
as the oligosaccharide extended the intensity of the
diene fragments (Zi/Zi fragments) decreased. These
fragment formations were also accompanied by the loss
ectra of LNFP III-alditol (Gal1-4(Fuc1-3)Glc-
H] ion of m/z 854 and (b) MS3-spectrum of the
for identification of a C-3 and C-4 disubstitutedn-sp
[M
ment
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than the disubstituted GlcNAc (m/z 655.2 and m/z 637.2
Figure 4c).
Since the diene was diagnostic for a C-3 and C-4
disubstituted GlcNAc, it was not possible to determine
which of these was the attachment site for Gal1- and
Fuc1- of this GlcNAc in the structures found on the
salivary MUC5B Lewis type oligosaccharides (Table 1).
In one case, two isomers were found (retention time
13.4 min and 15.3 min, respectively) with the same
indistinguishable sequence and linkage information
([M  H] ion of m/z 879 with the sequence Fuc-Hex-
3/4(Fuc-3/4)HexNAc-3HexNAcol). An obvious expla-
nation for the presence of these two isomers is a Lewis
b structure (Fuca1-2Gal1-3(Fuc1-4)GlcNAc1-3Gal-
NAcol) and a Lewis y structure (Fuca1-2Gal1-4(Fuc1-
3)GlcNAc1-3GalNAcol). Both Lewis b and Lewis y
have been found in saliva [24]. The graphitized carbon
chromatography has a tendency to retain Type 2 struc-
tures longer than Type 1 structures (Table 1). Hence, the
Lewis y structure is probably the later eluting isomer.
Fucosylated Terminal Structures, Blood Group H
(Fuc1-2Gal1-), Blood Group A (Fuc1-
2(GalNAc1-3)Gal1-), and Blood Group B
(Fuc1-2(Gal1-3)Gal1-)
In general, Yi and Zi cleavages produced by loss of
terminal fucose were never found to be of high intensity
(20%). This was particularly true for the Fuc1-2 in
the oligosaccharides with blood group H-determinants.
The Yi- and Zi-fragments that result from the cleavage
of the disaccharide sequence of the Fuc1-2Gal1-
tended to be of higher intensity than from only cleavage
of the single Fuc1-2 (e.g., compare the Z3 ion of m/z
568.9 with Z2 ion of m/z 407.0 in Figure 2d). Interest-
ingly, blood group H Type 1 structures, but not H Type
2 structures, showed weak fragments from the GlcNAc-
diene pathway, similar to Lewis type structures. How-
ever, the free hydroxyl on the C-4 of the GlcNAc in an
H Type 1 structure (only C-3 extended) eliminated to a
lesser extent than the Lewis type GlcNAc (C-3 and C-4
extended) (compare the Z2 CH4O2 fragment in Figure
2d with the Z2/Z2  CH2O fragment in Figure 2e).
Cross ring cleavages of blood group H determinants
including the fucose and part of the galactose (1,3A2
fragment) could be detected in the fragments of the
smaller structures (e.g., m/z 205 in Figure 2b and Figure
5b), but this could not be used to non-ambiguously
assign the fucose to the C-2 of galactose, without further
confirmation with other linkage isomers. Non-reducing
end blood group H-determinant fragments also in-
cluded weak B2- and C2-cleavages (e.g., m/z 306.9 and
m/z 324.8 in Figure 5b). These fragments could be
accompanied with additional loss (e.g., B2  C2H4O2 of
m/z 246.7 in Figure 2b, d, and Figure 5b). Fragmentation
of blood group H-containing oligosaccharide alditol
standards showed that this particular fragment wasindicative for C-2 substituted galactose (data not
shown), but the exact origin of the fragment could not
be determined.
The majority of structures in this report were from a
blood group O (or blood group H) individual. Hence, it
was not expected that blood group A or B containing
structures would be found among the detected struc-
tures. To gain insight into these kinds of epitopes,
oligosaccharides were analyzed from other sources.
Oligosaccharides from MUC5B from one blood group
A/B individual and one blood group A individual were
isolated as well as porcine gastric mucin oligosaccha-
rides. While the two former samples were shown to be
dominated by more Lewis b/y containing structures
extended into blood group A and B structures (exem-
plified in Figure 4), porcine gastric mucins contained
fewer and shorter structures (exemplified in Figure 2c).
A number of these structures were thoroughly ana-
lyzed, and it could be concluded that fragmentation of
a C-3 and C-2 substituted Gal (Figure 2c) would not
induce a diene formation, as was the case for a C-3 and
C-4 substituted GlcNAc.
From the data set presented here it appears that no
truly diagnostic cross ring fragments for the ABO type
epitopes could be found. However, the presence of
these epitopes can be suggested from the primary
oligosaccharide sequence elucidated by the glycosidic
cleavages using MS2 fragmentation. Linkage specific
fragment ions from oligosaccharides containing Lewis
b/y extended with blood group A or B (GalNAc/
Gal1-3(Fuc1-2)Gal1-3/4(Fuc1-4/3)GlcNAc1-),
could be more easily identified since C-3 and C-4
disubstituded GlcNAc gives characteristic Zi/Zi frag-
ment ions (Figure 4 a and b) (Table 3), similar to that
described previously for Lewis a/x.
Conclusions
Informative MS2 spectra of neutral mucin type O-linked
oligosaccharide alditols in negative ion mode were
obtained, consisting mainly of reducing end fragment
ions. The core type was predicted from the first daugh-
ter ion spectrum together with the mode of elongation
(Type 1 or 2 chains) and terminal epitopes such as
Lewis a/x and Lewis b/y together with the ABO-blood
group antigens were indicated. For obtaining informa-
tion on the overall glycosylation of mucins, the terminal
epitopes described here can also be detected sensitively
with antibodies. However, there are few immunono-
logical methods to obtain information about core type
or elongation type, since these epitopes could be hid-
den, and generic antibodies are not available. Tradition-
ally to obtain this information, extensive oligosaccha-
ride structural characterization by methylation analysis
or 1H-NMR would be necessary, requiring large
amounts of purified material.
The linkage information from MS2 was based on
either pattern (e.g., intensity of Zi- versus Yi-fragment
ions of GalNAcol C-3), or the presence or absence of
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H]  C3H8O4 fragment ion diagnostic for Core 1 and
Core 3, the 4Ai fragment ion indicative of the C-6
extension on GalNAcol (Core 2 and Core4), the 0,2Ai 
H2O fragment ion for Type 2 chains and the Zi/Zi
double cleavage fragment ions from C-3 and C-4 disub-
stituted GlcNAc (Table 3). The identities of these pre-
dicted fragments were verified by MS3 or isotopic
labeling. The applicability of this approach for analyz-
ing mucin oligosaccharides was illustrated with the
structural identification of 50 different neutral oligosac-
charides from human salivary MUC5B (Table 1). The
negative ion fragmentation of the neutral mucin oligo-
saccharide alditols was quite different from similar
structures isolated from milk with a reducing end Glc
instead of GalNAcol [10, 11, 25]. While the fragmenta-
tion of milk oligosaccharides is dominated by non-
reducing end fragments, mucin oligosaccharide alditols
give more reducing end fragments. This suggests that
some of the diagnostic reducing end fragments described
here will only be observed on oligosaccharide alditols. We
have observed that the diene formation of Lewis type
structures, as described here, will only occur on reduced
Table 3. Fragmentation pattern observed for fragmentation of m
Epitope
C-3 cleavage of GalNAcol
Cleavage type (relative intensity)
Diagno
Cleava
Core 1 less than 4
residues
Zi (50–100 %), [M  H
[M  H
Core 1 more than
3 residues
[M  H]  223 (1–10 %),
[M  H]  108 (1–5 %)
Zi and Y (10 %)
Core 2 Zi (50–100 %),
4Ai-cle
(1–2
Core 3 less than
5 residues
Zi (20–100 %), [M  H
[M  H
Core 4 Zi 50–100 %, Y (5–35 %)
4Ai-cle
(1–2
Type 1 Zi and Yi (50–100 %)
Equal in size if type 1 on C-3
Type 2 Mostly Zi (50–100 %)
if type 2 branch on C-3
0,2Ai-H
(2–1
Lewis a/x Mostly Yi (50–100 %)
if epitope on C-3
[M  H
[M  H
(5–1
Lewis y/b Mostly Yi (50–100 %)
if epitope on C-3
[M  H
[M  H
(5–1
Blood group H Lewis
and
(Zi/Z
Blood group A/B A Lew
69
(Zi/Z
B Lew
65
(Zi/ZLewis a/x containing LNFPII and LNFPIII oligosaccha-
rides, but not with their reducing counterparts.
The amount of saliva used for LC-MS2 in any one
experiment corresponded to 50 L of the total 5–10 mL
starting material. The emphasis in this report was not
the sensitivity, but rather to acquire enough fragmen-
tation data in order to be able to distinguish general
patterns and pathways. We have shown that this ap-
proach of characterizing oligosaccharides from mucins
isolated by gel electrophoresis is applicable to even less
material [14], and this report, describing a detailed MS2
fragmentation of mucin oligosaccharides, is a continu-
ation of this work. The use of negative ion electrospray
mass spectrometry is shown in this report to be able to
provide substantial information on the structure of the
oligosaccharides attached to proteins. Combined with
the improvements in the isolation of glycoproteins, the
release of the oligosaccharides and the separation of
structural isomers by chromatography, the time needed
for this type of analysis is being reduced. The bottleneck
for higher throughput analysis of oligosaccharides is
now at the level of the complex data analysis. This
emphasizes the future need for good oligosaccharide
type oligosaccharides
ions
pe (relative intensity) Other features
223 (1–100 %)
108 (1–5 %)
e of GalNAcol
223 (1–100 %)
108 (1–5 %)
e of GalNAcol
eavage of GlcNAc
)
344 and
374 (Zi/Zi cleavages)
)
loss of Gal1-3/4 mostly Yi (10 %)
loss of Fuc1-3/4 (2 %)
490 and
520 (Zi/Zi cleavages)
)
loss of Fuc1-2/3/4 (10 %)
ives [M  H]  490
H]  520
vages) (5–100 %)
loss of Fuc1-2 mostly Yi (10 %)
gives [M  H]
[M  H]  723
vages) (5–100 %)
loss of Gal1-3 or GalNAc1-3 Yi
and Zi (20 %)
gives [M  H]
[M  H]  682
vages) (5–100 %)ucin
stic
ge ty
] 
] 
avag
0 %)
] 
] 
avag
0 %)
2O cl
00 %
] 
] 
00 %
] 
] 
00 %
y/b g
[M 
i clea
is y/b
3 and
i clea
is y/b
2 and
i clea
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